Table 5. Factors associated to Fecal Impaction in rectal examination.
| N | No Impaction | Impaction | OR not adjusted | |
| Age (years) | 687 | 84.2 (8.2) | 86,3 (7.3) | 1.04 (0.99–1.08) |
| Gender | ||||
| Male | 207 | 195 (94.2%) | 12 (5.8%) | 1 |
| Female | 480 | 448 (93.3%) | 32 (6.7%) | 1.16 (0.59–2.30) |
| Body Mass Index (kg/m2) | 643 | 25.2 (4.5) | 26.0 (4.2) | 1.04 (0.97–1.11) |
| Time of staying in nursing home (months) | 682 | 40.3 (45.0) | 50.6 (39.9) | 1.00 (1.00–1.01) |
| Functional Status (Barthel Index; score) | 642 | 63.3 (30.3) | 46,4 (30.5) | 0.98 (0.97–0.99) |
| Cognitive Status (Folstein Test; score) | 673 | 22.3 (8.6) | 23.6 (7.0) | 1.02 (0.98–1.06) |
| Modified Ward Index (score) | 687 | 3.9 (5.2) | 7.8 (5.0) | 1.12 (1.07–1.17) |
| Fibre intake (g/day) | 665 | 9.6 (3.6) | 8.3 (4.2) | 0.89 (0.80–0.98) |
| Liquids intake (l/day) | 664 | 1.6 (0.4) | 1.3 (0.5) | 0.29 (0.13–0.63) |
| Physical activity | ||||
| Sport or long walks | 71 | 70 (98.6%) | 1 (1.4%) | 1 |
| Light or moderate | 407 | 378 (92.9%) | 29 (7.1%) | 5.37 (0.72–40.07) |
| Minimal | 191 | 179 (93.7%) | 12 (6.3%) | 4.69 (0.60–36.77) |
| Number of co-morbidities | 687 | 2.8 (1.4) | 4.3 (18.8) | 1.77 (1.46–2.15) |
| Diabetes | ||||
| No | 501 | 476 (95.0%) | 25 (5.0%) | 1 |
| Yes | 186 | 167 (89.8%) | 19 (10.2%) | 2.17 (1.16–4.04) |
| Thyroid diseases | ||||
| No | 610 | 575 (94.3%) | 35 (5.7%) | 1 |
| Yes | 77 | 68 (88.3%) | 9 (11.7%) | 2.17 (1.00–4.72) |
| High blood pressure | ||||
| No | 285 | 274 (96.1%) | 11 (3.9%) | 1 |
| Yes | 402 | 369 (91.8%) | 33 (8.2%) | 2.23 (1.11–4.49) |
| Cardiovascular diseases | ||||
| No | 413 | 399 (96.6%) | 14 (3.4%) | 1 |
| Yes | 274 | 244 (89.1%) | 30 (10.9%) | 3.50 (1.82–6.74) |
| Respiratory diseases | ||||
| No | 512 | 496 (96.9%) | 16 (3.1%) | 1 |
| Yes | 175 | 147 (84.0%) | 28 (16.0%) | 5.90 (3.11–11.21) |
| Parkinson's Disease | ||||
| No | 641 | 598 (93.3%) | 43 (6,7%) | 1 |
| Yes | 46 | 45 (97.8%) | 1 (2.2%) | 0.31 (0.04–2.30) |
| Stroke | ||||
| No | 539 | 506 (93.9%) | 33 (6.1%) | 1 |
| Yes | 148 | 137 (92.6%) | 11 (7.4%) | 1.23 (0.61–2.50) |
| Other Neurological diseases | ||||
| No | 400 | 372 (93.0%) | 28 (7.0%) | 1 |
| Yes | 287 | 271 (94.4%) | 16 (5.6%) | 0.78 (0.42–1.48) |
| Osteoarthritis | ||||
| No | 268 | 259 (96.6%) | 9 (3.4%) | 1 |
| Yes | 419 | 384 (91.6%) | 35 (8.4%) | 2.62 (1.24–5.55) |
| Renal/Urinary Diseases | ||||
| No | 586 | 551 (94.0%) | 35 (6.0%) | 1 |
| Yes | 101 | 92 (91.1%) | 9 (8.9%) | 1.54 (0.72–3.31) |
| Constipation | ||||
| No | 201 | 200 (99.5%) | 1 (0.5%) | 1 |
| Controlled | 201 | 196 (97.5%) | 5 (2.5%) | 5.10 (0.59–44.07) |
| Uncontrolled | 257 | 222 (86.4%) | 35 (13.6%) | 31.53 (4.28–232.27) |
| Anxiety Disorder | ||||
| No | 492 | 469 (95.3%) | 23 (4.7%) | 1 |
| Yes | 195 | 174 (89.2%) | 21 (10.8%) | 2.46 (1.33–4.56) |
| Depression | ||||
| No | 428 | 411 (96.0%) | 17 (4.0%) | 1 |
| Yes | 259 | 232 (89.6%) | 27 (10.4%) | 2.81 (1.50–5.27) |
| Other Psychiatric diseases | ||||
| No | 641 | 600 (93.6%) | 41 (6.4%) | 1 |
| Yes | 46 | 43 (93.5%) | 3 (6.5%) | 1.02 (0.30–3.43) |
| Abdominal Surgery | ||||
| No | 548 | 508 (92.7%) | 40 (7.3%) | 1 |
| Yes | 139 | 135 (97.1%) | 4 (2.9%) | 0.38 (0.13–1.07) |
| Number of drugs | 687 | 4.0 (2.2) | 6.2 (2.1) | 1.46 (1.28–1.67) |
| Antihypertensive | ||||
| No | 281 | 272 (96.8%) | 9 (3.2%) | 1 |
| Regular | 403 | 368 (91.3%) | 35 (8.7%) | 2.87 (1.36–6.08) |
| Occasional | 3 | 3 (100.0%) | 0 (0.0%) | |
| SSRIs | ||||
| No | 441 | 422 (95.7%) | 19 (4.3%) | 1 |
| Regular | 245 | 220 (89.8%) | 25 (10.2%) | 2.52 (1.36–4.68) |
| Occasional | 1 | 1 (100.0%) | 0 (0.0%) | |
| Tricyclic Antidepressant | ||||
| No | 668 | 625 (93.6%) | 43 (6.4%) | 1 |
| Regular | 19 | 18 (94.7%) | 1 (5.3%) | 0.81 (0.11–6.19) |
| Benzodiazepines | ||||
| No | 488 | 460 (94.3%) | 28 (5.7%) | 1 |
| Regular | 193 | 177 (91.7%) | 16 (8.3%) | 1.49 (0.78–2.81) |
| Occasional | 6 | 6 (100.0%) | 0 (0.0%) | |
| Hypolipemics | ||||
| No | 515 | 486 (94.4%) | 29 (5.6%) | 1 |
| Regular | 170 | 155 (91.2%) | 15 (8.8%) | 1.62 (0.85–3.10) |
| Occasional | 2 | 2 (100.0%) | 0 (0.0%) | |
| PPIs | ||||
| No | 258 | 240 (93.0%) | 18 (7.0%) | 1 |
| Regular | 408 | 385 (94.4%) | 23 (5.6%) | 0.80 (0.42–1.51) |
| Occasional | 21 | 18 (85.7%) | 3 (14.3%) | 2.22 (0.60–8.26) |
| Antiacids | ||||
| No | 655 | 616 (94.0%) | 39 (6.0%) | 1 |
| Regular | 25 | 22 (88.0%) | 3 (12.0%) | 2.15 (0.62–7.51) |
| Occasional | 7 | 5 (71.4%) | 2 (28.6%) | 6.32 (1.19–33,61) |
| Calcium channel blockers | ||||
| No | 607 | 573 (94.4%) | 34 (5.6%) | 1 |
| Regular | 80 | 70 (87.5%) | 10 (12.5%) | 2.41 (1.14–5.08) |
| Nitrates | ||||
| No | 627 | 595 (94.9%) | 32 (5.1%) | 1 |
| Regular | 59 | 47 (79.7%) | 12 (20.3%) | 4.75 (2.29–9.82) |
| NSAID | ||||
| No | 517 | 492 (95.2%) | 25 (4.8%) | 1 |
| Regular | 79 | 68 (86.1%) | 11 (13.9%) | 3.18 (1.50–6.76) |
| Occasional | 91 | 83 (91.2%) | 8 (8.8%) | 1.90 (0.83–4.35) |
| ASA | ||||
| No | 463 | 449 (97.0%) | 14 (3.0%) | 1 |
| Regular | 223 | 193 (86.5%) | 30 (13.5%) | 4.99 (2.59–9.61) |
| Opiates | ||||
| No | 620 | 581 (93.7%) | 39 (6.3%) | 1 |
| Regular | 62 | 59 (95.2%) | 3 (4.8%) | 0.76 (0.23–2.53) |
| Occasional | 5 | 3 (60.0%) | 2 (40.0%) | 9.93 (1.61–61.19) |
| Antidiarrheals | ||||
| No | 672 | 628 (93.5%) | 44 (6.5%) | 1 |
| Regular | 5 | 5 (100.0%) | 0 (0.0%) | |
| Occasional | 10 | 10 (100.0%) | 0 (0.0%) | |
| Anticholinergics | ||||
| No | 628 | 586 (93.3%) | 42 (6.7%) | 1 |
| Regular | 59 | 57 (96.6%) | 2 (3.4%) | 0.49 (0.12–2.08) |
| Diuretics | ||||
| No | 406 | 396 (97.5%) | 10 (2.5%) | 1 |
| Regular | 258 | 230 (89.1%) | 28 (10.9%) | 4.82 (2.30–10.11) |
| Occasional | 23 | 17 (73.9%) | 6 (26.1%) | 13.98 (4.55–42.94) |
| Phenothiazines | ||||
| No | 650 | 607 (93.4%) | 43 (6.6%) | 1 |
| Regular | 37 | 36 (97.3%) | 1 (2.7%) | 0.39 (0.05–2.93) |
| Hypnotics | ||||
| No | 507 | 474 (93.5%) | 33 (6.5%) | 1 |
| Regular | 155 | 147 (94.8%) | 8 (5.2%) | 0.78 (0.35–1.73) |
| Occasional | 25 | 22 (88.0%) | 3 (12.0%) | 1.96 (0.56–6.88) |